Healthcare provider profile · identity verified

Jill K Postel, PA

Physician Assistant · BRIGHTON, CO · NPI 1609813492

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	407	110
Atorvastatin Calcium	Atorvastatin Calcium	201	63
Losartan Potassium	Losartan Potassium	186	52
Gabapentin	Gabapentin	182	54
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	152	27
Omeprazole	Omeprazole	152	42
Lisinopril	Lisinopril	149	41
Simvastatin	Simvastatin	146	37
Amlodipine Besylate	Amlodipine Besylate	128	37
Tramadol Hcl	Tramadol Hcl	124	28
Trazodone Hcl	Trazodone Hcl	112	28
Hydrochlorothiazide	Hydrochlorothiazide	106	32
Pantoprazole Sodium	Pantoprazole Sodium	103	31
Lorazepam	Lorazepam	90	30
Sertraline Hcl	Sertraline Hcl	90	24
Potassium Chloride	Potassium Chloride	83	26
Rosuvastatin Calcium	Rosuvastatin Calcium	81	26
Meloxicam	Meloxicam	79	28
Pregabalin	Pregabalin	75	19
Montelukast Sodium	Montelukast Sodium	72	20
Metformin Hcl	Metformin Hcl	71	22
Alprazolam	Alprazolam	70	14
Escitalopram Oxalate	Escitalopram Oxalate	68	23
Albuterol Sulfate Hfa	Albuterol Sulfate	66	27
Oxycodone Hcl	Oxycodone Hcl	66	14
Metoprolol Succinate	Metoprolol Succinate	63	21
Furosemide	Furosemide	62	21
Alendronate Sodium	Alendronate Sodium	61	19
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	61	17
Duloxetine Hcl	Duloxetine Hcl	61	16
Prednisone	Prednisone	61	25
Famotidine	Famotidine	58	15
Bupropion Xl	Bupropion Hcl	56	18
Celecoxib	Celecoxib	56	18
Fluoxetine Hcl	Fluoxetine Hcl	55	14
Buspirone Hcl	Buspirone Hcl	50	20
Temazepam	Temazepam	50	suppressed
Methylprednisolone	Methylprednisolone	48	41
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	47	suppressed
Synthroid	Levothyroxine Sodium	47	14
Eliquis	Apixaban	45	15
Topiramate	Topiramate	45	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	44	15
Fluconazole	Fluconazole	43	15
Valacyclovir	Valacyclovir Hcl	43	16
Fluticasone Propionate	Fluticasone Propionate	42	14
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	40	12
Cephalexin	Cephalexin	39	28
Tamsulosin Hcl	Tamsulosin Hcl	39	11
Venlafaxine Hcl Er	Venlafaxine Hcl	39	11
Azithromycin	Azithromycin	38	27
Oxybutynin Chloride Er	Oxybutynin Chloride	38	14
Doxycycline Hyclate	Doxycycline Hyclate	37	31
Warfarin Sodium	Warfarin Sodium	36	suppressed
Clonazepam	Clonazepam	35	suppressed
Donepezil Hcl	Donepezil Hcl	35	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	35	24
Carvedilol	Carvedilol	33	suppressed
Nystatin	Nystatin	32	suppressed
Memantine Hcl	Memantine Hcl	31	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	31	18
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	29	21
Ondansetron Odt	Ondansetron	29	15
Propranolol Hcl Er	Propranolol Hcl	29	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	29	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	28	11
Lovastatin	Lovastatin	27	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	27	20
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	26	suppressed
Mirtazapine	Mirtazapine	26	suppressed
Valsartan	Valsartan	26	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	25	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	25	suppressed
Estradiol	Estradiol	23	12
Mounjaro	Tirzepatide	23	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	22	suppressed
Baclofen	Baclofen	21	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	20	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	20	suppressed
Sucralfate	Sucralfate	20	suppressed
Mupirocin	Mupirocin	19	16
Ozempic	Semaglutide	19	suppressed
Xarelto	Rivaroxaban	19	suppressed
Clonidine Hcl	Clonidine Hcl	18	suppressed
Cefpodoxime Proxetil	Cefpodoxime Proxetil	17	suppressed
Citalopram Hbr	Citalopram Hydrobromide	17	suppressed
Diclofenac Sodium	Diclofenac Sodium	17	suppressed
Glimepiride	Glimepiride	17	suppressed
Liothyronine Sodium	Liothyronine Sodium	17	suppressed
Nabumetone	Nabumetone	17	suppressed
Allopurinol	Allopurinol	16	suppressed
Amoxicillin	Amoxicillin	16	13
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	16	suppressed
Diazepam	Diazepam	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Ventolin Hfa	Albuterol Sulfate	16	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	15	suppressed
Metformin Hcl Er	Metformin Hcl	15	suppressed
Spironolactone	Spironolactone	15	suppressed
Prazosin Hcl	Prazosin Hcl	14	suppressed
Ropinirole Hcl	Ropinirole Hcl	14	suppressed
Ezetimibe	Ezetimibe	13	suppressed
Meclizine Hcl	Meclizine Hcl	13	suppressed
Prempro	Estrogen,con/M-Progest Acet	13	suppressed
Tizanidine Hcl	Tizanidine Hcl	13	suppressed
Acyclovir	Acyclovir	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Cholestyramine	Cholestyramine (With Sugar)	12	suppressed
Clobetasol Propionate	Clobetasol Propionate	12	suppressed
Fesoterodine Fumarate Er	Fesoterodine Fumarate	12	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	12	suppressed
Jardiance	Empagliflozin	12	suppressed
Lidocaine	Lidocaine	12	suppressed
Morphine Sulfate Er	Morphine Sulfate	12	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	12	suppressed
Oxycontin	Oxycodone Hcl	12	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	12	12
Zolpidem Tartrate	Zolpidem Tartrate	12	suppressed
Azelastine Hcl	Azelastine Hcl	11	suppressed
Ibuprofen	Ibuprofen	11	suppressed
Ketoconazole	Ketoconazole	11	suppressed
Nebivolol Hcl	Nebivolol Hcl	11	suppressed
Olanzapine	Olanzapine	11	suppressed
Rizatriptan	Rizatriptan Benzoate	11	suppressed
Trulicity	Dulaglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error